Everolimus
Actiza
['everolimus', 'rcc,(-irccs),(-srcc),(-urcc)', 'everest']
everest (adjuvant everolimus post-rn or pn): subset analysis of chromophobe (n=99) &amp; papillary rcc (n=109) no dfs benefit--&gt; chr (hr:0.89, p=0.79) &amp; pap (hr:1.19, p=0.61) no os benefit--&gt; chr (hr:0.93, p=0.89) &amp; pap (hr:1.47, p=0.34) #asco23 
MD, MSc | @UofTUrology @SUO_YUO Fellow & @IHPMEUofT CEHCR PhD| Previously: @MCG_Urology and @AUB_Lebanon 🇱🇧